A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening

Drug development for specific antiviral agents against coronavirus disease 2019 (COVID-19) is still an unmet medical need as the pandemic continues to spread globally. Although huge efforts for drug repurposing and compound screens have put forth, only few compounds remain in late stage clinical tri...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:bioRxiv
Autors principals: Gorshkov, Kirill, Vasquez, Desarey Morales, Chiem, Kevin, Ye, Chengjin, Tran, Bruce Nguyen, de la Torre, Juan Carlos, Moran, Thomas, Chen, Catherine Z., Martinez-Sobrido, Luis, Zheng, Wei
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282096/
https://ncbi.nlm.nih.gov/pubmed/34268508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.07.03.450938
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars